Position in AMGN
as of Jun 30, 2026
· filed Jul 28, 2026
Position Value
$834,324
+$7,477 QoQ
Shares Held
2,304
-2.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
#1,816
of 3,140 holders
Holding Since
Mar 2024
10 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026ANGELES WEALTH MANAGEMENT, LLC holds $30,855,204 across 12 Drug Manufacturers - General names. AMGN ranks #6 (2.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
7,926 | $9,506,682 | |
| 2 | ABBV |
AbbVie Inc.
|
23,439 | $5,898,189 | |
| 3 | JNJ |
Johnson & Johnson
|
20,743 | $5,268,099 | |
| 4 | MRK |
Merck & Co., Inc.
|
37,088 | $4,765,808 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
20,763 | $1,196,364 | |
| 6 | AMGN |
Amgen Inc
This page
|
2,304 | $834,324 | |
| 7 | NVO |
Novo Nordisk A S
|
16,884 | $809,418 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
5,920 | $747,932 |
All Filings in AMGN
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $834,324 | 2,304 | Shares | Sole | 2026-07-28 | |
| 2026-03-31 | $826,847 | 2,350 | Shares | Sole | 2026-05-06 | |
| 2025-12-31 | $662,802 | 2,025 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $281,917 | 999 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $366,881 | 1,314 | Shares | Sole | 2025-07-29 | |
| 2025-03-31 | $316,846 | 1,017 | Shares | Sole | 2025-05-07 | |
| 2024-12-31 | $230,666 | 885 | Shares | Sole | 2025-01-28 | |
| 2024-09-30 | $281,289 | 873 | Shares | Sole | 2024-10-29 | |
| 2024-06-30 | $258,708 | 828 | Shares | Sole | 2024-08-07 | |
| 2024-03-31 | $209,543 | 737 | Shares | Sole | 2024-05-08 | |
| No filing history on record for this holder in this stock. | ||||||